Related Links
This FOA builds upon previous and current Division of HIV/AIDS Prevention (DHAP) programs, initiatives, and guidelines. Funded program activities must be consistent with relevant CDC-supported programmatic guidance and recommendations including, but not limited to:
- PS14-1403: Capacity Building Assistance for High-Impact HIV Prevention
- Recommendations for HIV prevention with adults and adolescents with HIV in the United States, 20142;
- Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014
- The CDC Recommendations for Partner Services Programs for HIV Infection, Syphilis, Gonorrhea, and Chlamydial Infection
- The CDC Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health Care Settings
- The CDC, the Health Resources and Services Administration (HRSA), the National Institutes of Health (NIH), and the HIV Medicine Association of the Infectious Disease Society of American (IDSA) Guidelines for Incorporating HIV Prevention into the Medical Care of Persons Living with HIV
- Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
- Division of HIV/AIDS Prevention (DHAP) social marketing campaign initiatives
- Combating the Silent Epidemic: U.S. Department of Health and Human Services Action Plan for the Prevention, Care and Treatment of Viral Hepatitis.
Other National Public Health Priorities and Strategies
- The National HIV/AIDS Strategy.
- CDC DHAP Strategic Plan,
- Accelerating Improvements in HIV Prevention and Care in the United States through the HIV Care Continuum Initiative (White House Executive Order),
- Minority AIDS Initiative (MAI),
- CDC Winnable Battles: HIV Focus Area,
National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)
- Page last reviewed: March 13, 2017
- Page last updated: March 13, 2017
- Content source: Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention